Fibrous tissue accumulation is an integral feature of the adverse structural remodeling of myocardial tissue following a cardiac insult. Given the importance of fibrous tissue in leading to myocardial dysfunction and failure, noninvasive assessment of fibrosis could prove a clinically useful tool, particularly given the potential for cardioprotective and cardioreparative pharmacological strategies. This approach represents an exciting and innovative strategy, and available data set the stage for large-scale and long-term trials, where this noninvasive assessment of myocardial fibrosis in patients with hypertensive heart disease and other cardiac diseases could prove useful...